Methylphenidate transdermal (Taho Pharma)

N/A

Report date: 2023/09/06 17:58:20

Base Information

Drug NameMethylphenidate transdermal (Taho Pharma)
Drug Alias NameMethylphenidate transdermal patch (Taho Pharma)ADHD-TAH9901TAH-9901
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine transporter antagonists
TargetsDopamine transporter
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTAHO Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTAHO Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A